Global private equity and venture capital news and research

Posts Tagged ‘cancer’

3 December 2015

SV Life Sciences among consortium backing £19m Kesios Therapeutics Series A

microscope-275984_1920 SV Life Sciences and Imperial Innovations were among a syndicate of investors in a £19m Series A financing round for cancer treatment business Kesios Therapeutics.

28 September 2015

Atlas Venture-led consortium helps fund latest Replimune cancer research

lab-217041_1280 Early-stage investment firm Atlas Venture has headed a group of investors to successfully close a $30m financing round for Oxford-based cancer therapeutics firm Replimune.

18 May 2015

Scottish Equity Partners backs ovarian cancer screener in £5.25m round

lab glass Scottish Equity Partners has co-led a £5.25m funding round for life sciences business Abcodia to help bring its ovarian cancer screening test to market.

23 April 2015

Wellington, Redmile back $56m for cancer fighting company Jounce

lab-work-803087-m Venture capital investors Wellington Management Company, Redmile Group and Nextech Invest have backed a $56m Series B round for cancer immunotherapeutics developer Jounce Therapuetics.

24 March 2015

New VCs help anti-cancer treatment pioneer Rigontec push Series A to €14.25m

Dutch early stage investor Forbion Capital Partners and Danish peer Sunstone Capital have brought biopharma business Rigontec's Series A round to €14.25m through a second close.

4 February 2015

Lightspeed drives $50m Series C for cancer analysis company Guardant Health

life science test tube_sq Lightspeed Venture Partners has led a $50m Series C funding round for Guardant Health, which has a vision of transforming cancer into a manageable disease.

9 January 2015

NEA, Atlas among VC backers $35m Surface Oncology Series A

Opsona research lab Cancer immunotherapy business Surface Oncology has picked up $35m of Series A financing from a string of venture capital firms.

14 November 2014

Anti-cancer business Blueprint Medicines bags $50m VC-backed Series C

blueprint_real_estate_170sq A string of venture capital firms have backed a $50m Series C financing round for cancer treatment developer Blueprint Medicines.

30 September 2014

Montagu to make 2x return in €1bn Euromedic exit deal $

blue-first-aid-box-911384-m European major Montagu Private Equity will double its money selling its stake in pan-European medical services provider Euromedic International, AltAssets has learned.

26 September 2014

Vestar-backed 21st Century Oncology gets $325m CPPIB investment

21st century oncology Canadian pension giant CPPIB has invested $325m in Vestar Capital-backed cancer treatment centre network 21st Century Oncology Holdings.

Page 1 of 41234

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2016